Edgewise Therapeutics Inc. Common Stock vs Liberty Media Corporation Series C Liberty Formula One Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Liberty Media Corporation Series C Liberty Formula One Common Stock trades at $90.97 (market cap $22.59B). The key difference: Liberty Media Corporation Series C Liberty Formula One Common Stock is far larger — about 5.6× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Liberty Media Corporation Series C Liberty Formula One Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Liberty Media Corporation Series C Liberty Formula One Common Stock for 0 Days on average.
| EWTX | FWONK | |
|---|---|---|
Market Cap | $4.02B | $22.59B |
Volume | 1,446,128 | 2,257,903 |
Sector | Health | Media |
52-Week High | $48.35 | $106.66 |
52-Week Low | $14.89 | $81.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $26.05B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Liberty Media Corporation's Series C Liberty Formula One common stock is a tracking stock reflecting the economic performance of the Formula One Group, which holds Liberty Media's interests in Formula 1 racing, MotoGP, and related minority investments.
Read more on FWONK →